Get the Stockscreener App
1.36
0.73%
-0.01
After Hours:
1.36
Overview
News
Price History
Option Chain
Financials
Why PETS Down?
Discussions
Forecast
Stock Split
Dividend History
Petmed Express Inc stock is traded at $1.36, with a volume of 185.18K.
It is down -0.73% in the last 24 hours and down -27.08% over the past month.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
See More
Previous Close:
$1.37
Open:
$1.36
24h Volume:
185.18K
Relative Volume:
0.92
Market Cap:
$29.48M
Revenue:
$179.02M
Net Income/Loss:
$-57.29M
P/E Ratio:
-0.4948
EPS:
-2.7487
Net Cash Flow:
$-33.01M
1W Performance:
-11.11%
1M Performance:
-27.08%
6M Performance:
-40.61%
1Y Performance:
-47.69%
1-Day Range:
$1.33
$1.37
1-Week Range:
$1.33
$1.53
52-Week Range:
$1.33
$4.10
Petmed Express Inc Stock (PETS) Company Profile
Name
Petmed Express Inc
Sector
Industry
Phone
(561) 426-4444
Address
420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Compare PETS vs HITI, MEDS, POM, SCNX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PETS
Petmed Express Inc
|
1.36 | 33.17M | 179.02M | -57.29M | -33.01M | -2.7487 |
HITI
High Tide Inc
|
2.63 | 248.71M | 486.49M | -33.29M | 10.86M | -0.3627 |
MEDS
Trxade Health Inc
|
3.68 | 9.94M | 7.15M | 4.03M | -11.33M | -5.40 |
POM
Pomdoctor Ltd Adr
|
0.86 | 9.64M | 0 | 0 | 0 | 0.00 |
SCNX
Scienture Holdings Inc
|
0.1588 | 11.39M | 656.60K | -16.79M | -11.12M | -1.0743 |
Petmed Express Inc Stock (PETS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-25-23 | Initiated | Lake Street | Buy |
| Jan-20-22 | Upgrade | Sidoti | Neutral → Buy |
| Nov-18-21 | Initiated | Morgan Stanley | Underweight |
| Oct-01-21 | Initiated | Jefferies | Hold |
| Aug-05-21 | Resumed | Credit Suisse | Underperform |
| Jun-03-21 | Downgrade | Sidoti | Buy → Neutral |
| Mar-05-21 | Upgrade | Sidoti | Neutral → Buy |
| Jan-27-21 | Downgrade | Sidoti | Buy → Neutral |
| Aug-19-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-09-20 | Downgrade | Sidoti | Buy → Neutral |
| Mar-12-20 | Upgrade | Sidoti | Neutral → Buy |
| Feb-24-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-16-19 | Downgrade | Craig Hallum | Buy → Hold |
| Jun-15-18 | Initiated | CL King | Neutral |
| Aug-24-17 | Upgrade | Sidoti | Neutral → Buy |
| Jul-24-17 | Upgrade | Northcoast | Neutral → Buy |
| May-09-16 | Upgrade | Craig Hallum | Sell → Hold |
| Feb-04-16 | Initiated | Credit Suisse | Underperform |
| Jul-19-10 | Downgrade | CL King | Strong Buy → Accumulate |
| Jul-19-10 | Reiterated | JMP Securities | Mkt Outperform |
| May-25-10 | Downgrade | Wedbush | Neutral → Underperform |
| May-06-10 | Reiterated | Wedbush | Neutral |
| Mar-23-10 | Downgrade | Janney Mntgmy Scott | Buy → Neutral |
| Mar-18-10 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-16-10 | Reiterated | CL King | Strong Buy |
| Jul-21-09 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-09 | Initiated | CL King | Strong Buy |
View All
Petmed Express Inc Stock (PETS) Latest News
Cash flow from operating activities of PetMed Express, Inc. – HAN:PQM - TradingView
PetMed Express CEO Jeffrey Willard Granted 500,000 Shares in Equity Awards - kalkinemedia.com
PetMed Express CEO Jeffrey Allen Willard Files Initial SEC Ownership Disclosure - kalkinemedia.com
A 250,000-share restricted award goes to PetMed Express (PETS) CEO. Another grant hinges on returns. - Stock Titan
Jeffrey Allen Willard, CEO and president of PetMed Express (PETS), is named in an initial ownership report. - Stock Titan
PetMed Express stock gets a new CEO after a 500,000-share plan - AD HOC NEWS
PetMed Express Files to Register 1.8 Million Additional Shares Under Updated 2024 Incentive Plan - kalkinemedia.com
PetMed names Jeffrey Allen Willard as CEO with equity grants under amended plan - TradingView
PetMed Express Is Maintained at Underweight by Morgan Stanley - Moomoo
PETS Maintains Rating by Morgan Stanley -- Price Target Lowered to $1.40 - GuruFocus
Form 8K PetMed Express Inc For: 22 September By Investing.com - Investing.com Australia
PetMed Express Q2 2026 Earnings: Reported Loss of $0.28 Per Share Swings Sharply Below ConsensusRevenue Breakdown Analysis - siam.in
PETMED EXPRESS INC (NASDAQ: PETS) Appoints Tamar Elkeles, Expanding Board to Five Directors - kalkinemedia.com
PetMed Express stock gains as new director joins board and governance roles - AD HOC NEWS
PetMed Express appoints Tamar Elkeles to board of directors By Investing.com - Investing.com Nigeria
PetMed Express appoints Tamar Elkeles to board of directors - Investing.com
PetMeds Appoints Tamar Elkeles to Board Amid Leadership Transition - citybiz
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director - The Manila Times
Qualcomm’s former talent chief joins PetMeds’ board - Stock Titan
PetMed Express Names Jeff Willard CEO Amid Transformation - The Globe and Mail
PetMed (PETS) Stock Analysis: -0.63% Loss — Key Levels 2026-09-17Large Cap Trends - careplusvn.com
PetMeds names Jeff Willard as CEO, Campbell to retire By Investing.com - Investing.com Australia
PetMeds names Jeff Willard as CEO, Campbell to retire - Investing.com
PetMeds Names Jeff Willard CEO as Justin Mennen Becomes Board Chair - citybiz
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition - The Manila Times
PetMeds will get a new CEO Sept. 28 as its board chair retires - Stock Titan
PetMeds Names Andrew Parry CTO to Lead E-Commerce and Pharmacy Technology - citybiz.co
PetMeds Appoints Andrew Parry as Chief Technology Officer - The Manila Times
PetMed Express names Andrew Parry as chief technology officer By Investing.com - Investing.com Australia
PetMed Express names Andrew Parry as chief technology officer - Investing.com
PetMed Express, Inc. Announces Appointment of Andrew Parry to Chief Technology Officer, Effective September 14, 2026 - marketscreener.com
PetMed Express, Inc. (PETS) Stock Price & News - Syfe
PetMed Express Inc. (PETS) Peer Comparison – Compare with Others - Value Research
PetMed Express Inc. (PETS) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
PetMed Express Inc. (PETS) Key Financial Ratios – Valuation, Profitability & More - Value Research
PetMed Express (PETS) Advances to $1.88, Holding Above Key Support in Low-Priced RangeVolume Dry Up - vinanet.vn
PetMed Express Inc. (PETS) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
PetMeds (PETS) Q1 FY2027 Results Show Stabilizing Revenue but No Margin Relief Yet - AlphaStreet
PetMed Express (PETS) Q1 2027 Earnings Call Transcript - AOL.com
Petwealth and Kennel Connection Accelerate Partnership Following Strong Industry Response at SuperZoo 2026 - AOL.com
PetMed (PETS) Financial Update: EPS Falls Short of Its Estimate at the Close; After Earnings: The Stock Loses 1.67% in Latest TradingShare Repurchase Impact - vinanet.vn
150-year-old Cheltenham pharmacy rescued from administration - AOL.co.uk
Petmed Express Inc (PETS) Stock News Today - TradingKey
Full Transcript: PetMed Express Q1 2027 Earnings Call - Sahm
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y - Yahoo Finance
PetMed Express Q1 2027 Earnings Call Transcript - MarketBeat
PetMed Express (PETS) Fiscal Q1 2027 Earnings Call: Sales Stabilize Above $40 Million - TradingKey
PetMeds® Announces First Quarter Financial Results - The Manila Times
PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Na - GuruFocus
PetMed Express earnings missed by $0.40, revenue fell short of estimates - Investing.com Canada
PetMed Express, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
Petmed Express Inc Stock (PETS) Financials Data
Revenue
Net Income
Cash Flow
EPS
9.36%
2.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):